Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2005
10/05/2005EP1581553A1 Enzymes and polynucleotides encoding the same
10/05/2005EP1581337A2 Composition for separating molecules
10/05/2005EP1581253A2 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents
10/05/2005EP1581164A2 Compositions and methods for inhibiting tumor growth and metastasis
10/05/2005EP1470219A4 Peroxide-driven cytochrome p450 oxygenase variants
10/05/2005EP1461758A4 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
10/05/2005EP1294393B1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
10/05/2005EP1071471A4 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
10/05/2005EP1034278B1 Method for the production of glycerol by recombinant organisms
10/05/2005CN1678754A Primer and probe for detecting vibrio vulnificus and detection method using the same
10/05/2005CN1678752A Analytical method for the determination of infant formula protein digestibility in vitro
10/05/2005CN1678750A Electrochemical sensing using an enzyme electrode
10/05/2005CN1678748A Plants having changed development and a method for making the same
10/05/2005CN1678746A Flavanoid 3', 5'hydroxylase gene sequences and uses therefor
10/05/2005CN1678742A Novel aldolase and production process of substituted alpha-keto acids
10/05/2005CN1678736A Thermostable ribonuclease H
10/05/2005CN1678735A Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
10/05/2005CN1678636A Thrombus-resolving and anticoagulation double function fusion protein and use thereof
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1676607A Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use
10/05/2005CN1676606A Method for reconstructing target protein from protein segment in plant
10/05/2005CN1676605A Method for producing bacterial xylanase
10/05/2005CN1676604A Method for preparing liver hydrogen peroxidase
10/05/2005CN1221664C Production of five-carbon sugars and sugar alcohols
10/05/2005CN1221661C Method for preparing lysozyme
10/05/2005CN1221648C Redeposition or backstain inhibition during stonewashing process
10/05/2005CN1221284C Medicine for treating diabetes
10/04/2005US6951969 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951917 major histocompatability complex (MHC-class II); human leukocyte antigen; recognized by CD4 lymphocytes; immunogens; vaccines; immunotherapy
10/04/2005US6951751 DNA and amino acid sequences of a tyrosine-inducible tyrosine ammonia lyase enzyme from the yeast Trichosporon cutaneum
10/04/2005US6951750 Prolidase and its gene and method for producing prolidase
10/04/2005US6951749 Carboxypeptidases and nucleic acids encoding same
10/04/2005US6951747 Polyhydroxyalkanoate synthase and gene encoding the same
10/04/2005US6951745 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
10/04/2005US6951744 Nucleotide sequence amplification; obtain nucleotide sequences, incubate with reaction mixture, digest with pyrophosphatase, amplify nucleotide sequences
10/04/2005US6951743 Transgenic cell for use in producing hyaluronic acid
10/04/2005US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics
10/04/2005US6951722 Method for amplifying nucleic acid sequence
10/04/2005US6951720 Use of phosphorothiolate polynucleotides in ligating nucleic acids
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005CA2214996C Process for producing formed product of deproteinized natural rubber latex and deproteinizing agent for natural rubber latex
10/04/2005CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g
09/2005
09/29/2005WO2005090995A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility
09/29/2005WO2005090991A1 Adam8 as tumor marker and therapeutic target for non-small cell lung cancer
09/29/2005WO2005090595A2 Nitrile hydratases from metagenome libraries
09/29/2005WO2005090590A1 Method for producing l-amino acids from d-amino acids
09/29/2005WO2005090588A1 Acetylation of aniline derivative by microbe and enzyme derived from microbe
09/29/2005WO2005090587A1 Method of removing enzyme and method of base exchange or hydrolysis of phospholipid using the same
09/29/2005WO2005090581A1 Improved constructs for marker excision based on dual-function selection marker
09/29/2005WO2005090578A1 Sclerotinia resistance gene
09/29/2005WO2005090577A1 Expression of nitrille hydratases in a two-vector expression system
09/29/2005WO2005090560A1 Prostatic acid phosphatase antigens
09/29/2005WO2005090559A1 Methods and compositions involving s-ship promoter regions
09/29/2005WO2005090552A2 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
09/29/2005WO2005090395A2 Methods for increasing protein polyethylene glycol (peg) conjugation
09/29/2005WO2005090394A2 Cyanide tolerant nitrilhydratases
09/29/2005WO2005089792A1 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
09/29/2005WO2005089737A2 Materials and methods for inhibiting wip1
09/29/2005WO2005089505A2 Detection, isolation and uses of renalase (monoamine oxidase c)
09/29/2005WO2005089471A2 Increased stress tolerance and enhanced yield in plants
09/29/2005WO2005089411A2 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
09/29/2005WO2005089379A2 Antirotational structure for wave energy converters
09/29/2005WO2005089378A2 Wave energy converters (wecs) with linear electric generators (legs).
09/29/2005WO2005089295A2 WAVE ENERGY CONVERTERS (WECs) WITH VELOCITY MULTIPLICATION
09/29/2005WO2005089284A2 Wave energy converter (wec) with magnetic braking
09/29/2005WO2005089182A2 Improved bacterial host cell for the direct expression of peptides
09/29/2005WO2005089102A2 Methods of refolding mammalian glycosyltransferases
09/29/2005WO2005089070A2 Thrombin derivatives and medicinal composition containing the same
09/29/2005WO2005089047A2 Glycosylated glucocerebrosidase expression in fungal hosts
09/29/2005WO2005089040A2 Method of producing chymosin c and uses thereof
09/29/2005WO2005080559B1 Fungall cell wall degrading enzyme
09/29/2005WO2005078076A3 Tpl2 and its expression
09/29/2005WO2005073364A3 Advanced microorganism for producing 1,2-propanediol
09/29/2005WO2005056757A3 A method for the positive selection of chromosomal mutations in c1 metabolizing bacteria via homologous recombination
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005052144A3 Method for producing phospholipase a2
09/29/2005WO2005051976A3 Protein and peptide ligation processes and one-step purification processes
09/29/2005WO2005045020A3 Enzymatic synthesis, modification and decomposition of silicon(iv) compounds and other metal(iv) compounds
09/29/2005WO2005024011A3 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
09/29/2005WO2005007843A3 Amino acid-substituted coagulation factor v
09/29/2005WO2005007820A3 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity
09/29/2005WO2005003336A3 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
09/29/2005WO2004085618A3 Method of screening for target ligands
09/29/2005WO2004063355A3 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
09/29/2005WO2004061120A3 Nucleic acids encoding ranpirnase variants and methods of making them
09/29/2005WO2004042011A3 Promotion of peroxisomal catalase function in cells
09/29/2005WO2004037991A3 Prkcb1 as modifier of branching morphogenesis and methods of use
09/29/2005WO2004031365A3 Sulfatases and methods of use thereof
09/29/2005US20050216975 Nucleotide sequences coding oxidoreductase for use in transfer, expression and production of omega-3 and omega-6 fatty acids in yarrowia
09/29/2005US20050216973 Plant vitamin E biosynthetic enzymes
09/29/2005US20050216961 Cancer associated protein kinases and their uses
09/29/2005US20050216959 Using biobolistic electric discharge particle acceleration to transfer gold coated beads into cells; improving heterologous gene transfer and expression
09/29/2005US20050216958 Fucosyltransferase knock-out host cell for use as bioreactors in production of preferentially modified glycoproteins
09/29/2005US20050215775 70 human secreted proteins
09/29/2005US20050215505 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215483 Peptide inhibitors of protein kinase c
09/29/2005US20050214944 Using single-stranded nucleic acids and homologus recombination to correct defects in tumor suppressor genes; treating and preventing cell proliferative disorders; gene therapy